The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Caruso James V since year 2005.
The trader's CIK number is 1202770.
At the time of this reporting, Caruso James V is the President and CEO of Cellectar Biosciences, Inc. .
(stock ticker symbol CLRB).
See this page for all insider trading activities at Cellectar Biosciences, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-11-30 | CLRB | Cellectar Biosciences, Inc. | Buy | 1,000 | 2.28 | 2,282 |
| 2018-03-12 | CLRB | Cellectar Biosciences, Inc. | Sale | 34,000 | 1.20 | 40,698 |
| 2016-04-20 | CLRB | Cellectar Biosciences, Inc. | Buy | 46,948 | 2.12 | 99,529 |
| 2015-11-24 | CLRB | Cellectar Biosciences, Inc. | Buy | 1,000 | 1.30 | 1,302 |
| 2015-11-20 | CLRB | Cellectar Biosciences, Inc. | Buy | 1,000 | 1.16 | 1,159 |
| 2015-11-18 | CLRB | Cellectar Biosciences, Inc. | Buy | 2,000 | 1.40 | 2,790 |
| 2015-11-19 | CLRB | Cellectar Biosciences, Inc. | Buy | 2,000 | 1.50 | 3,000 |
| 2010-03-01 | ALTH | Allos Therapeutics Inc | Sale | 77,500 | 8.13 | 630,075 |
| 2010-03-01 | ALTH | Allos Therapeutics Inc | Option Ex | 40,000 | 3.13 | 125,200 |
| 2010-02-23 | ALTH | Allos Therapeutics Inc | Sale | 5,968 | 7.44 | 44,378 |
| 2009-08-10 | ALTH | Allos Therapeutics Inc | Option Ex | 85,400 | 3.13 | 267,302 |
| 2009-08-10 | ALTH | Allos Therapeutics Inc | Sale | 85,400 | 8.13 | 694,302 |
| 2009-08-03 | ALTH | Allos Therapeutics Inc | Option Ex | 50,000 | 3.13 | 156,500 |
| 2009-08-03 | ALTH | Allos Therapeutics Inc | Sale | 50,000 | 7.79 | 389,500 |
| 2009-08-05 | ALTH | Allos Therapeutics Inc | Option Ex | 14,600 | 3.13 | 45,698 |
| 2009-08-05 | ALTH | Allos Therapeutics Inc | Sale | 14,600 | 8.13 | 118,756 |
| 2009-06-15 | ALTH | Allos Therapeutics Inc | Sale | 14,000 | 8.13 | 113,820 |
| 2009-06-16 | ALTH | Allos Therapeutics Inc | Sale | 13,500 | 8.16 | 110,119 |
| 2009-03-26 | ALTH | Allos Therapeutics Inc | Option Ex | 39,500 | 3.13 | 123,635 |
| 2009-03-25 | ALTH | Allos Therapeutics Inc | Sale | 6,900 | 7.13 | 49,203 |
| 2009-03-26 | ALTH | Allos Therapeutics Inc | Sale | 39,500 | 7.37 | 291,194 |
| 2009-03-25 | ALTH | Allos Therapeutics Inc | Option Ex | 6,900 | 3.13 | 21,597 |
| 2009-03-12 | ALTH | Allos Therapeutics Inc | Option Ex | 50,000 | 3.13 | 156,500 |
| 2009-03-16 | ALTH | Allos Therapeutics Inc | Sale | 3,600 | 7.13 | 25,671 |
| 2009-03-16 | ALTH | Allos Therapeutics Inc | Option Ex | 3,600 | 3.13 | 11,268 |
| 2009-03-12 | ALTH | Allos Therapeutics Inc | Sale | 50,000 | 7.13 | 356,500 |
| 2008-09-02 | ALTH | Allos Therapeutics Inc | Sale | 10,000 | 9.68 | 96,800 |
| 2007-06-06 | ALTH | Allos Therapeutics Inc | Sale | 10,000 | 5.62 | 56,150 |
| 2006-12-29 | ALTH | Allos Therapeutics Inc | Buy | 2,500 | 3.05 | 7,627 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Caruso James V (President and CEO of Cellectar Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.